Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Pasithea Therapeutics Corp

KTTA
Current price
3.64 USD -0.04 USD (-1.09%)
Last closed 3.7 USD
ISIN US70261F1030
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 3 970 658 USD
Yield for 12 month -51.44 %
1Y
3Y
5Y
10Y
15Y
KTTA
21.11.2021 - 28.11.2021

Pasithea Therapeutics Corp., a biotechnology company, engages in discovery, research, and development of treatments for central nervous system disorders, RASopathies, and other diseases. Its lead product candidate PAS-004, a next-generation macrocyclic mitogen-activated protein kinase, or MEK inhibitor for use in the treatment of a range of RASopathies, including neurofibromatosis type 1 oncology indications. The company intends to develop PAS-003, to treat amyotrophic lateral sclerosis; and PAS-001, to treat schizophrenia. Pasithea Therapeutics Corp. was incorporated in 2020 and is headquartered in Miami Beach, Florida. Address: 1111 Lincoln Road, Miami Beach, FL, United States, 33139

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

2 USD

P/E ratio

Dividend Yield

Current Year

+486 559 USD

Last Year

+486 559 USD

Current Quarter

Last Quarter

Current Year

-648 454 USD

Last Year

+373 364 USD

Current Quarter

-162 256 USD

Last Quarter

-162 258 USD

Key Figures KTTA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -16 274 925 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -37.9 %
PEG Ratio
Return On Equity TTM -63.25 %
Wall Street Target Price 2 USD
Revenue TTM 486 559 USD
Book Value 15.49 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 1498.1 %
Dividend Yield
Gross Profit TTM -2 213 USD
Earnings per share -14.79 USD
Diluted Eps TTM -14.79 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics KTTA

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History KTTA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:20
Payout Ratio
Last Split Date 02.01.2024
Dividend Date

Stock Valuation KTTA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 277.4414
Price Sales TTM 42.1513
Enterprise Value EBITDA 2.9009
Price Book MRQ 0.2455

Financials KTTA

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators KTTA

For 52 weeks

3.4 USD 9.6 USD
50 Day MA 4.47 USD
Shares Short Prior Month 171 290
200 Day MA 5.9 USD
Short Ratio 0.01
Shares Short 22 799
Short Percent 2.76 %